Recently, an increased TRPML1 expression level has been correlated with poor clinical outcomes of pancreatic ductal adenocarcinoma patients [193], significantly lowering overall survival. The gene discussed is MCOLN1; the disease is pancreatic ductal adenocarcinoma.